Johnson & Johnson has promoted Sheri McCoy to Worldwide Chairman, Pharmaceuticals Group, and Alex Gorsky to Worldwide Chairman, Surgical Care Group.
Surface Logix has named Keith Dionne as President and CEO.
Antares Pharma has appointed Paul K. Wotton, Ph.D., as President and CEO.
Theron Odlaug, Ph.D. has been promoted to CEO at CyDex Pharmaceuticals.
Dr. Steven S. Lee, Ph.D., has been appointed CEO of A-Bio Pharma.
Pharming Group has named Sijmen de Vries as CEO.
Oxford BioMedica appointed John Dawson as Chief Executive Officer.
Sinobiomed has appointed Lionel Choong as the Company's CFO.
Excaliard has appointed Lincoln Krochmal, MD, President & CEO and Jeffrey Jenson, Head of Clinical Operations.
Dr. Mel Spigelman, Director of Synergy Pharmaceuticals, has been appointed President and CEO of Global Alliance For TB Drug Development.
BioNanomatrix has elected Dr. Pui-Yan Kwok to Its Scientific Advisory Board.
Gerard A. Martino has resigned as COO of Par Pharmaceuticals.
Milestone Scientific has appointed Joseph D'Agostino CFO.
BioReliance Corporation has named Andrew Paterson Ph.D. as Senior Director/General Manager for UK Operations.
Abraxis BioScience has named Edward Geehr, M.D., Executive VP of Operations.
PDL BioPharma has elected Paul Sandman and John McLaughlin to its Board of Directors.
Synvista Therapeutics has appointed William Federici to its Board of Directors.
Antares Pharma has elected Dr. Leonard S. Jacob as Chairman of the Board.
Craig Rosen, Ph.D., Biopharmaceutical Development Expert, has joined Phase Bioscience as Executive Chairman.
Synageva BioPharma has elected Dr. Mark Goldberg to Its Board of Directors.
Marie A. Bernard, M.D., has been named deputy director of the National Institute on Aging (NIA).
Axial Biotech has elected William L. Lister to the Board of Directors.
Aldagen has elected Lyle Hohnke, Ph.D. to the Board of Directors.